Condition: Acute Lymphoblastic Leukemia · Sponsor: Versailles Hospital
An observatory for patients aged 18 years and over with Philadelphia chromosome positive (Ph+ or BCR::ABL1) acute lymphoblastic leukemia (ALL) and treated with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticosteroids and/or a monoclonal antibody.
This description comes directly from the study's public registry record.
Sandrine Roux · +33139239777 · sroux@ght78sud.fr
Always discuss trial participation with your own doctor first.
| Groupe hospitalier sud | Amiens, France | Not Yet Recruiting |
| CHU Angers | Angers, France | Not Yet Recruiting |
| CH de la cote basque | Bayonne, France | Not Yet Recruiting |
| CHU Bordeaux | Bordeaux, France | Recruiting |
| Hopital Militaire Percy | Clamart, France | Not Yet Recruiting |
| CHU clermont ferrand | Clermont-Ferrand, France | Recruiting |
| Centre Hospitalier sud francilien | Corbeil-Essonnes, France | Recruiting |
| CHU de grenoble | Grenoble, France | Not Yet Recruiting |
| CHU Sud Réunion | La Réunion, France | Not Yet Recruiting |
| CH Versailles | Le Chesnay, France | Recruiting |
| CH Le Mans | Le Mans, France | Recruiting |
| Chu de Lille | Lille, France | Not Yet Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07684131